Drug Discovery Market Reports

Kalorama Information market research studies have the data you need on the drug discovery market opportunity, providing analysis, projections, and information on market direction. Drug discovery operations can prove time-consuming and difficult, and may come at a high economic cost, which has driven outsourcing in this field. Kalorama explores an important segment, the contract research organization segment, looking in detail at an approach that is helping to shape the drug discovery market today.

loading... Loading...
Published: | Price: {{result.PriceString}}
...

No reports match your search criteria.


RSS Subscription
{{ pageDetailsDisplay }}
Published: May 18, 2016 | Price: $0.00
This White Paper, Offshoring Contract Research Activities, provides insight into three regions of the world where CROs are assisting pharmaceutical companies in drug discovery activities.  More information can be obtained in Kalorama Information's complete report on the subject, Outsourcing in Drug...
Published: Apr 26, 2016 | Price: $4,200.00
Outsourcing in Drug Discovery, 7th Edition This Kalorama Information study, Outsourcing in Drug Discovery, provides details estimates and forecasts of the contract research organization market and an in depth look into the trends that have shaped the drug discovery outsourcing market today, and...
Published: Mar 17, 2015 | Price: $4,200.00
Lab Automation Markets, 4th Edition (Systems [Sample Transport, Specimen Handling, Plate Readers, Storage & Retrieval, Robotics, LIMS], Key Companies, Forecasts and Trends) Automation technology is an essential consideration in modern laboratory operation and efficiency. In many ways, the...
Published: Apr 30, 2014 | Price: $3,995.00
For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process.This Kalorama Information Report, Outsourcing in Drug Discovery, t provides an in depth look into the trends that have shaped the drug...
Published: Sep 19, 2013 | Price: $2,500.00
Laboratory Information Systems (LIS / LIMS) Markets (Clinical Laboratory Software and Hardware, Drug Discovery Systems) Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and...
Published: May 20, 2013 | Price: $1,500.00
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and as a result, the range of therapeutic options available to physicians and other...
Published: Feb 23, 2013 | Price: $3,995.00
This report, Lab Automation Markets, 3rd Edition, (Systems, Key Companies, Forecasts and Trends), represents Kalorama Information's latest study of the market for systems that enable labs to store, identify and transport large quantities of specimens.  The report analyzes the current and potential...
Published: Feb 11, 2013 | Price: $995.00
This report, The World Market for Implantable and Needle-Free Drug Delivery details the types of drug delivery systems and technologies that are being used in 2012, as well as those that may become major market factors by the end of the forecast period. The report describes the industry, its...
Published: Dec 4, 2012 | Price: $500.00
This Kalorama Information report – The Next Wave in Cancer Treatment--Kinase Inhibitors - is focused on a growing area of cancer treatment, kinase inhibitors. Several cancers are being treated with these newer therapies, which provide a focus of cancer profiled in this report,...
Published: Aug 14, 2012 | Price: $3,995.00
A nosocomial, or hospital-acquired, infection is a new infection that develops in a patient during hospitalization. It is usually defined as an infection that is identified at least forty-eight to seventy-two hours following admission, so infections incubating, but not clinically apparent, at...
Published: May 11, 2012 | Price: $3,995.00
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a target protein or nucleic acid in a way that is useful for treatment of disease. The...
Published: Jan 1, 2012 | Price: $1,995.00
There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists...
Published: May 1, 2011 | Price: $2,995.00
The future of the pharmaceutical market will be determined by biologics - drugs produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms for the treatment or management of diseases or injuries. What are the products that lead...
Published: Jun 1, 2010 | Price: $3,995.00
Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore...
Published: Mar 1, 2010 | Price: $3,995.00
This report, Lab Automation Markets analyzes the current and potential world markets for medical laboratory automation systems and equipment - both for clinical diagnostics and drug discovery research laboratories. Many clinical laboratories are facing a number of issues that are challenging...
Published: Oct 1, 2009 | Price: $3,500.00
The anti-infective market is at a critical juncture. For the past 60 years, antibiotic drugs have turned bacterial infections into treatable conditions rather than the life-threatening scourges they once were. But the effectiveness of many antibiotics is waning dramatically, as more and more...
Published: May 1, 2009 | Price: $995.00
The multi-billion veterinary health products market, though smaller in opportunity as compared with the human health sector, offers significant return on investment, primarily driven by lower risk and faster product development cycles. The veterinary health products market has remained resilient...
Published: Feb 1, 2009 | Price: $3,995.00
This Kalorama Information report - Clinical Nutrition - focuses on three primary segments of essential medical nutrition: Infant Nutrition: (Milk-based, Soy-based, Special Needs such as Chronic Reflux or Gastrointestinal Discomfort) Enteral Nutrition (Standard and Fiber-containing Elemental and...
Published: Jan 1, 2009 | Price: $995.00
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing...
Published: Oct 1, 2008 | Price: $3,500.00
Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are...
Published: Aug 1, 2008 | Price: $1,500.00
The benefits of automation in the clinical laboratory are well documented. They involve replacing manual, potentially dangerous, error-prone steps with automated processes requiring minimal operator intervention. This approach can increase productivity, decrease turnaround time, improve staff...
Published: Aug 1, 2008 | Price: $1,500.00
Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new...
Published: May 1, 2008 | Price: $3,500.00
2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term...
Published: Mar 1, 2008 | Price: $995.00
With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells. For market-watchers in the...
Published: Jan 1, 2008 | Price: $995.00
Rheumatoid arthritis and lupus belong to a number of autoimmune diseases affecting the musculoskeletal system, multisystemic tissue, and connective tissues. Although a range of autoimmune conditions carry a low prevalence, combined these diseases amount to a growing medical and economic burden. ...
Published: | Price: {{result.PriceString}}
...
{{ pageDetailsDisplay }}

No reports match your search criteria.